Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Allergan funds diabetes study

Allergan funds diabetes study

23rd January 2008

through a university grant, according to the New York Times.

The study is thought to be the first to compare weight-loss surgery and standard medical therapy as treatments for type 2 diabetes and was conducted at Monash University in Melbourne, Australia.

Preliminary research has indicated that obese patients with type 2 diabetes who opt to undergo gastric banding surgery are likely to lose more weight and may stand a better chance of going into remission than those who use more conventional methods to fight the disease.

Lead author Dr John B Dixon, an obesity researcher at the university, said surgery may become a more popular option for the treatment of diabetes in the coming years.

The New York newspaper reported that Dr Dixon also received research grants and speakers’ fees from Allergan, which offered travel grants for editorial writers to attend a diabetes surgery conference in Rome.

The full results of the study will be published today in the Journal of the American Medical Association (JAMA).

According to the JAMA, both obesity and type 2 diabetes may become widespread public health problems in the coming decades.

We currently have 6 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.